168 related articles for article (PubMed ID: 31928837)
1. Recombination-induced revertant mosaicism in ichthyosis with confetti and loricrin keratoderma.
Nomura T
J Dermatol Sci; 2020 Feb; 97(2):94-100. PubMed ID: 31928837
[TBL] [Abstract][Full Text] [Related]
2. Somatic recombination underlies frequent revertant mosaicism in loricrin keratoderma.
Suzuki S; Nomura T; Miyauchi T; Takeda M; Fujita Y; Nishie W; Akiyama M; Ishida-Yamamoto A; Shimizu H
Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30718378
[TBL] [Abstract][Full Text] [Related]
3. Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti.
Choate KA; Lu Y; Zhou J; Elias PM; Zaidi S; Paller AS; Farhi A; Nelson-Williams C; Crumrine D; Milstone LM; Lifton RP
J Clin Invest; 2015 Apr; 125(4):1703-7. PubMed ID: 25774499
[TBL] [Abstract][Full Text] [Related]
4. Ichthyosis with confetti: clinics, molecular genetics and management.
Guerra L; Diociaiuti A; El Hachem M; Castiglia D; Zambruno G
Orphanet J Rare Dis; 2015 Sep; 10():115. PubMed ID: 26381864
[TBL] [Abstract][Full Text] [Related]
5. Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: analysis of a family and review of the literature.
Gedicke MM; Traupe H; Fischer B; Tinschert S; Hennies HC
Br J Dermatol; 2006 Jan; 154(1):167-71. PubMed ID: 16403113
[TBL] [Abstract][Full Text] [Related]
6. Mitotic recombination in patients with ichthyosis causes reversion of dominant mutations in KRT10.
Choate KA; Lu Y; Zhou J; Choi M; Elias PM; Farhi A; Nelson-Williams C; Crumrine D; Williams ML; Nopper AJ; Bree A; Milstone LM; Lifton RP
Science; 2010 Oct; 330(6000):94-7. PubMed ID: 20798280
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal inversions as a hidden disease-modifying factor for somatic recombination phenotypes.
Nomura T; Suzuki S; Miyauchi T; Takeda M; Shinkuma S; Fujita Y; Nishie W; Akiyama M; Shimizu H
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563344
[TBL] [Abstract][Full Text] [Related]
8. Ichthyosis with confetti caused by new and recurrent mutations in KRT10 associated with varying degrees of keratin 10 mis-localization.
Pan Y; Feng C; Wang H; Lee M; Tang Z; Lin Z
J Dermatol Sci; 2020 Apr; 98(1):35-40. PubMed ID: 32113649
[TBL] [Abstract][Full Text] [Related]
9. Description of the natural course and clinical manifestations of ichthyosis with confetti caused by a novel KRT10 mutation.
Burger B; Spoerri I; Schubert M; Has C; Itin PH
Br J Dermatol; 2012 Feb; 166(2):434-9. PubMed ID: 21929535
[TBL] [Abstract][Full Text] [Related]
10. Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism.
Miyauchi T; Suzuki S; Takeda M; Peh JT; Aiba M; Natsuga K; Fujita Y; Takeichi T; Sakamoto T; Akiyama M; Shimizu H; Nomura T
Am J Hum Genet; 2021 Jun; 108(6):1026-1039. PubMed ID: 34004138
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of mutations in keratin 10 (KRT10) and the mitochondrial genome in a patient with ichthyosis with confetti and Leber's hereditary optic neuropathy.
Kalinska-Bienias A; Pollak A; Kowalewski C; Lechowicz U; Stawinski P; Gergont A; Kosinska J; Pronicka E; Kowalski P; Wozniak K; Ploski R
Am J Med Genet A; 2017 Nov; 173(11):3093-3097. PubMed ID: 28944608
[TBL] [Abstract][Full Text] [Related]
12. Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby.
Matsumoto K; Muto M; Seki S; Saida T; Horiuchi N; Takahashi H; Ishida-Yamamoto A; Iizuka H
Br J Dermatol; 2001 Oct; 145(4):657-60. PubMed ID: 11703298
[TBL] [Abstract][Full Text] [Related]
13. Treating epidermolytic ichthyosis and ichthyosis with confetti with epidermal autografts cultured from revertant skin.
Tanahashi K; Kono M; Yoshikawa T; Suzuki Y; Inoie M; Kuwatsuka Y; Kinoshita F; Takeichi T; Akiyama M
Br J Dermatol; 2024 May; ():. PubMed ID: 38739763
[TBL] [Abstract][Full Text] [Related]
14. Genetic Reversion via Mitotic Recombination in Ichthyosis with Confetti due to a KRT10 Polyalanine Frameshift Mutation.
Lim YH; Qiu J; Saraceni C; Burrall BA; Choate KA
J Invest Dermatol; 2016 Aug; 136(8):1725-1728. PubMed ID: 27208707
[No Abstract] [Full Text] [Related]
15. Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy.
Pasmooij AM; Jonkman MF; Uitto J
Discov Med; 2012 Sep; 14(76):167-79. PubMed ID: 23021371
[TBL] [Abstract][Full Text] [Related]
16. A novel microdeletion in LOR causing autosomal dominant loricrin keratoderma.
Kinsler VA; Drury S; Khan A; Waelchli R; Rukaite G; Barnicoat A; Lench N; Harper JI; O'Shaughnessy RF
Br J Dermatol; 2015 Jan; 172(1):262-4. PubMed ID: 25142840
[No Abstract] [Full Text] [Related]
17. Genetics. Mosaicism--switch or spectrum?
Davis BR; Candotti F
Science; 2010 Oct; 330(6000):46-7. PubMed ID: 20929800
[No Abstract] [Full Text] [Related]
18. Revertant mosaicism in a human skin fragility disorder results from slipped mispairing and mitotic recombination.
Kiritsi D; He Y; Pasmooij AM; Onder M; Happle R; Jonkman MF; Bruckner-Tuderman L; Has C
J Clin Invest; 2012 May; 122(5):1742-6. PubMed ID: 22466645
[TBL] [Abstract][Full Text] [Related]
19. Revertant mosaicism in genodermatoses.
Lim YH; Fisher JM; Choate KA
Cell Mol Life Sci; 2017 Jun; 74(12):2229-2238. PubMed ID: 28168442
[TBL] [Abstract][Full Text] [Related]
20. A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma.
Song S; Shen C; Song G; Mao X; Yan G; Wang X; Yan M; Zhong N
Br J Dermatol; 2008 Sep; 159(3):714-9. PubMed ID: 18844868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
